{
    "case_number": "CAC-UDRP-103021",
    "time_of_filling": "2020-04-22 09:38:39",
    "domain_names": [
        "spirivadosing.com"
    ],
    "case_administrator": "Šárka Glasslová (Case admin)",
    "complainant": [
        "Boehringer Ingelheim Pharma GmbH & Co KG"
    ],
    "complainant_representative": "Nameshield (Enora Millocheau)",
    "respondent": [
        "neeraj  manchanda"
    ],
    "respondent_representative": null,
    "factual_background": "FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT:\r\n\r\nThe Complainant is a German global research-driven pharmaceutical enterprise founded in 1885 with approximately 50,000 employees. The three business areas of BOEHRINGER are human pharmaceuticals, animal health and biopharmaceuticals. In 2019, net sales of the BOEHRINGER group of companies amounted to about EUR 18,997 million.\r\n\r\nThe drug which is produced under the SPIRIVA trademark is tiotropium bromide, a bronchodilator that relaxes muscles in the airways and increases air flow to the lungs. It is used to prevent bronchospasm in adults with chronic obstructive pulmonary disease, including bronchitis and emphysema. \r\n\r\nThe disputed domain name <spirivadosing.com> was registered on February 10, 2020 and redirects to a webpage in construction. \r\n",
    "other_legal_proceedings": "The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.",
    "no_response_filed": " No administratively compliant Response has been filed. ",
    "rights": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).",
    "no_rights_or_legitimate_interests": "The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).",
    "bad_faith": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).",
    "procedural_factors": "The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.",
    "decision": "Accepted",
    "panelists": [
        "Alfred Meijboom"
    ],
    "date_of_panel_decision": "2020-05-28 00:00:00",
    "informal_english_translation": "The Complainant owns several trademarks, including the following relevant trademark registrations:\r\n\r\n- the International trademark n° 692353 for the word mark “SPIRIVA”, registered on April 1, 1998 for goods in class 5, namely pharmaceutical and veterinary preparations; and\r\n\r\n- the International trademark n° 823202 for the word mark “SPIRIVA”, registered on March 18, 2004 for goods in class 10, namely instruments and apparatus for the inhalation of medicines.\r\n\r\nSuch trademarks are hereinafter individually and jointly referred to as the \"SPIRIVA\" trademarks.",
    "decision_domains": {
        "SPIRIVADOSING.COM": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}